Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,330 | 530 | 0 | 0 | 0 |
| TOTAL | $1,651 | $606 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,651 | $606 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 175 | 3,546 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 488 | 104 | 0 | 0 | 0 |
| Accrued Expenses | 276 | 134 | 0 | 0 | 0 |
| TOTAL | $939 | $3,783 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $939 | $3,783 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | N/A | N/A | N/A | N/A |
| Common Shares | 0 | 2,353 | 0 | 0 | 0 |
| Retained earnings | -30,385 | -28,080 | 0 | 0 | 0 |
| TOTAL | $712 | $-3,178 | $0 | $0 | $0 |
| Total Liabilities And Equity | $1,651 | $606 | $0 | $0 | $0 |